Back to Capital World Investors Capital World Investors

SYRESYRE
7 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in SPYRE THERAPEUTICS INC

Capital World Investors holds 2.3M shares of SYRE (SPYRE THERAPEUTICS INC), worth $205.6M as of 2026-Q2. The position was increased (+247.4% shares). SYRE represents 0.0% of Capital World Investors's portfolio.

Current Value

$205.6M

Current Shares

2.3M

Total Value Change

+$196.8M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+247.4%
$205.6M0.0%$88.78
49
2026-Q1
Increased
666,564
+233.0%
$33.6M0.0%$40.07
47
2025-Q4
Unchanged
200,172
0.0%
$6.6M0.0%$31.88
0
2025-Q3
Decreased
200,172
-42.9%
$3.4M0.0%$16.36
0
2025-Q2
Unchanged
350,774
0.0%
$5.3M0.0%$15.22
0
2025-Q1
Decreased
350,774
-7.3%
$5.7M0.0%$17.94
0
2024-Q4
New
378,573
-
$8.8M0.0%$22.54
38

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used